Copper(II)-glycyl-L-histidyl-L-lysine MOLECULAR FORMULA C 28 H 46 CuN 12 O 8 MOLECULAR WEIGHT 742.3 g/mol STRUCTURE Linear tripeptide PEPTIDE SEQUENCE Gly-His-Lys CHEMICAL STRUCTURE CAS Number: 300801-03-0 Molecular Formula : C 28 H 46 CuN 12 O 8 Source: PubChem Mechanism of Action GHK-Cu acts primarily by delivering bioavailable copper(II) to tissues and cells and modulating a range of biological pathways associated with repair and regeneration
ECTR is also suggested if the VPA concentration exceeds 900 mg/L, or if the patient has coma, respiratory depression requiring mechanical ventilation, acute hyperammonaemia, or pH 7.10 [7]
Dosing Considerations in Research Protocols IGF-1 LR3 is not FDA-approved for any clinical indication [15]
In recent years, researchers have identified the dual regulatory role played by exosomes, which can negatively or positively affect the activation of inflammasomes
Potential side effects include nausea, gastrointestinal discomfort, or headache